Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    rHIgM22
Show Display Options
Rank Status Study
1 Completed An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: rHIgM22
2 Recruiting An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse
Condition: Multiple Sclerosis, Acute Relapsing
Interventions: Drug: rHIgM22;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.